Loading insider details...
Latest Form 4 (Feb 18, 2026): Purchase of 4,000,000 ERNA shares, $2.00M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Feb 18, 2026 | Ernexa Therapeutics Inc. (ERNA) | Purchase | 4,000,000 | $2.00M |
| Jun 11, 2025 | Ernexa Therapeutics Inc. (ERNA) | Purchase | 21,241,163 | $2.22M |
| Apr 4, 2025 | Eterna Therapeutics Inc. (ERNA) | Purchase | 3,768,397 | $394.2K |
| Nov 5, 2024 | Eterna Therapeutics Inc. (ERNA) | Purchase | 261,756 | n/a |
| Dec 20, 2023 | Eterna Therapeutics Inc. (ERNA) | Purchase | 3,125,976 | $390.7K |
| Aug 25, 2023 | Eterna Therapeutics Inc. (ERNA) | Purchase | 2,307,692 | $288.5K |
| Dec 6, 2022 | Eterna Therapeutics Inc. (ERNA) | Purchase | 261,756 | $858.6K |
| Aug 3, 2022 | Brooklyn ImmunoTherapeutics, Inc. (BTX) | Grant/Award | 215,100 | n/a |
| Dec 10, 2021 | Brooklyn ImmunoTherapeutics, Inc. (BTX) | Other (see footnotes) | 92 | n/a |
| Jun 21, 2021 | Brooklyn ImmunoTherapeutics, Inc. (BTX) | Sale | 200,000 | $3.15M |